MSKCC Clinical Trials 2022

DCC-3014 for Giant Cell Tumor

18+

All Sexes

New York, NY

This trial is testing a new cancer drug, DCC-3014, in patients with solid tumors or a rare tumor of the tendon called tenosynovial giant cell tumor (TGCT). The trial has two parts: dose escalation (phase 1) and expansion (phase 2). In phase 1, both types of patients will be enrolled. In phase 2, only TGCT patients will be enrolled, in two different cohorts.

Phase 1 & 2

Waitlist Available

Has No Placebo

Learn More

MSKCCMaitreyi Sharma, MDDeciphera Pharmaceuticals, LLC

Glofitamab + Obinutuzumab for Non-Hodgkin's Lymphoma

18+

All Sexes

New York, NY

This trial tests glofitamab, a new drug given through an IV that helps immune cells attack cancer cells. It targets patients who need new treatment options because their cancer hasn't responded to existing treatments. The drug works by connecting immune cells to cancer cells, making it easier for the immune system to destroy the cancer. Glofitamab shows promise in treating certain types of blood cancers.

Phase 1 & 2

Waitlist Available

Has No Placebo

Learn More

MSKCCClinical TrialsHoffmann-La Roche

AAT + Corticosteroids for Graft-versus-Host Disease

Any Age

All Sexes

New York, NY

This trial will compare the effectiveness of a combination of AAT and corticosteroids to corticosteroids alone as the first treatment for patients at high risk for developing acute GVHD.

Phase 3

Waitlist Available

Drug

Learn More

MSKCCStudy DirectorCSL Behring

View All Trials at Mskcc

Is this your site?

Every week patients are viewing your profile. Claim your page to easily update information, respond to patients, and more!

Claim Profile